Caryn Lerman and Heinz Josef Lenz
Jun 13, 2025, 10:56
Caryn Lerman: Heinz Josef Lenz Provided Expanded Data From the CheckMate Clinical Trial at the ASCO 2025
Caryn Lerman, Director of Norris Comprehensive Cancer Center at Keck Medicine of USC, shared a post on LinkedIn:
“Heinz Josef Lenz, Deputy Director for Research Programs at USC Norris and Professor of Medicine and Cancer Biology at the Keck School of Medicine of USC, provided a presentation at the American Society of Clinical Oncology annual meeting during which he provided expanded data from the CheckMate clinical trial, a practice-changing trial that led to the FDA approving a new first line combination therapy for patients with microsatellite instability-high/DNA mismatch repair colorectal cancer.”
Read OncoDaily’s Special Articles from ASCO25:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 26, 2025, 04:02
Jul 26, 2025, 03:52
Jul 26, 2025, 03:45
Jul 26, 2025, 03:33
Jul 25, 2025, 22:02
Jul 25, 2025, 21:34
Jul 25, 2025, 21:01
Jul 25, 2025, 20:41
Jul 25, 2025, 20:07